A trusted team and reliable services to deliver your biopharmaceutical products to market.
Delivering comprehensive end-to-end services, we aim to be the integrated global CDMO partner of choice for the global biopharma industry. We have deep expertise and high speed of execution in product development and manufacturing with a wide range of capabilities from cell line and process development through to scale up, cGMP manufacturing and fill/finish of proteins and peptides and other large molecules. Our team enables our partners to accelerate the development and commercialization of biological and pharmaceutical products for unmet patient needs, delivering solutions for complex projects from our state-of-the-art R&D, scale-up and cGMP manufacturing facilities.
Offering process development, scale-up, and manufacturing services for biologics and sterile injectables from a dedicated, state-of-the-art facility, our aim is to be a full-service vaccine CDMO player and the go-to partner for global biopharmaceutical companies. We are already partnered with some of the leading global companies for the launch of their products in international markets.
At Stelis Biosource our core values are:
We operate with the highest degree of integrity and transparency without compromise. Our people, products, and processes display integrity, always.
Our team members and colleagues collaborate to deliver synergy and excellence in all our activities, actions, and decisions, ensuring we deliver high customer advocacy at all times. We commit to: • Be non-hierarchical and inclusive • Embrace diverse perspectives with curiosity and respect • Provide transparent and comprehensive communication with customers • Strive to make our services best-in-class.
We display entrepreneurial zeal towards work, delivering high-quality services and safe, superior products efficiently. We commit to: • Achieve cost leadership via operational excellence • Innovate to delight our employees, customers and community • Commit to the highest standards of quality • Ensure safety and well-being of our employees • Achieve ESG (Environment, Social, Governance) criteria.
CEO and Managing Director designate, Mark provides Stelis with strong leadership and is responsible for driving its aggressive growth and ensuring profitability. He leads the company’s overall strategy and provides the necessary direction and dynamic leadership across R&D, manufacturing, business development, and commercial operations.
Mark has over 25 years’ experience in the industry and has led a number of large-scale business transformations helping many of the world’s renowned companies to achieve record highs in revenue and profit. Before joining Stelis, Mark was the Chief Business Officer (CBO) for AGC Biologics (AGC), one of the world’s leading global biopharmaceutical CDMOs.
Mark W. Womack
CEO and Managing Director designate
CFO and Executive Director at Stelis Biopharma. P R Kannan is a senior finance professional with significant experience in M&A, Listing, QIP and fundraising. A Chartered Accountant and a Certified Management accountant by trade he is results-oriented with established track record of scaling up organizations.
P R Kannan
CFO and Executive Director
Vishvesh comes with over 28 years of international working experience in leading biopharmaceutical companies and academic institutions.
Prior to joining Stelis, he was with Dr. Reddy’s Laboratories, Hyderabad as Vice President – Quality and Partner Operations, Biologics Division since 2011 where he was instrumental in establishing a Quality Function, designed and rolled out an efficient Quality Management to enable the integration of quality throughout the product lifecycle, leveraged the Strategy Deployment Process (SDP) framework for designing and enabling processes for anytime audit readiness and successfully lead Biologics Business Unit in over 40 National and International Regulatory Audits.
Vishvesh Kumar Bhupathiraju
Sr. Vice President & Head - Quality Management
Anand was instrumental in setting up a world class protein formulation & analytics group at Biocon. He has over 22 years’ experience in research & has led CMC development of several biosimilars (MABs, Insulin analogues) & novel molecules as per the requirements of global regulatory bodies. His expertise includes process development, scale up, technology transfer, troubleshooting formulation development & protein analytical development & characterization.
Dr. Anand Khedkar
Sr. Vice President, R&D
Milan has over two decades of experience in creating business values in Biotech and Pharmaceutical industry worldwide. Before venturing into Business Development activities, he worked as an Engineer on project for setting up one of the biggest IV fluid facility. At Stelis his goal is to establish global footprints of Stelis products.
Prior to joining Stelis, he was Director of Business Development at Apotex and worked for companies like Mabxience and Intas where he established global presence for Biosimilars in regulated and emerging markets. Milan has been instrumental in successfully concluding more than 70 licensing collaboration agreements covering Biosimilars, Biologics and Specialty Pharmaceuticals across North America, Japan, China, Russia, South East Asia, Europe and Middle East.
Milan Doshi
Sr. Vice President, Global BD
Prateek heads the Process Development function at Stelis with a focus on outlining and implementing the strategy, structure, systems and processes, goals, and building strong capabilities to meet the customer needs.
Prateek has over 22 years of experience including international roles in leading biopharmaceutical companies and academic institutions, with significant leadership experience in the development of biomolecules for better health.
Prior to joining Stelis, he was Senior General Manager and Head of Process Science, R & D at Intas Pharmaceuticals, Ahmedabad where he was responsible for the overall technical and operational strategy for the development of cell lines and processes for the company’s biosimilar portfolio.
Dr. Prateek Gupta
VP, Head of Process Science
Non-Executive Director & Chairperson. Former MD of HDFC Bank, India's largest private sector bank, Aditya was the longest-serving head of any private bank in the country. India Today ranked him at #24 in India's 50 Most Powerful People of 2017 list. He is qualified as a Chartered Accountant with the Institute of Chartered Accountants of India and has many accolades in his fold.
Independent Director & Chairperson of Audit Committee, Vineeta Rai is a former IAS officer and the first woman to hold the post of Revenue Secretary in the Ministry of Finance. She has held posts in the Ministry of Urban Development, Ministry of Health & Family Welfare and Ministry of Home Affairs. She was voted one of the 25 Most Powerful Women in business in India in 2004.
Founder, a first-generation entrepreneur with an intellect of picking "difficult to operate" domains with high scarcity value. Recipient of the E&Y Entrepreneur of the year award in the Healthcare sector in 2000, Business Today "India Best CEO Award (Mid-Sized Companies Category)," and the "Best CEO in the Pharma & Healthcare Industry" in 2014.
Principal at TPG Growth, based in Mumbai. He has worked on investments in multiple sectors, including healthcare, Energy, and Consumer sectors across India and the broader South-Asia region. He also serves on the Boards of Cancer Treatment Services International, Rhea Healthcare, and Sutures India.
Partner, TPG Growth, Co-Founder, Akna Medical Pvt Ltd, Former Advisory Leader, Grant Thornton. He has significant experience in private equity, mergers and acquisitions, valuations, healthcare, medical devices, life sciences, business improvement, and capital markets.
CFO and Executive Director at Stelis Biopharma. Senior finance professional with significant experience in M&A, Listing, QIP and Fund raise. He is Chartered Accountant and a Certified Management accountant. Result Oriented with established track record of scaling up organizations.